ArticleJournal of cellular and molecular medicine2020

Identification of immune-enhanced molecular subtype associated with BRCA1 mutations, immune checkpoints and clinical outcome in ovarian carcinoma.

Mingjun Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.